Trial Profile
A cohort study to evaluate effect of bevacizumab in patients with metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer; Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2016 New trial record